Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $10.1400 (10.82%) ($9.0700 - $10.5000) on Fri. May. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.12% (three month average) | RSI | 68 | Latest Price | $10.1400(10.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 5.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 4.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(43%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -4.06% in a week (0% probabilities). VIXM(-31%) VXX(-27%) UNG(-10%) UUP(-8%) TLT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.06% (StdDev 8.12%) | Hourly BBV | 0 () | Intraday Trend | 9.5% | | | |
|
5 Day Moving Average | $9.06(11.92%) | 10 Day Moving Average | $8.79(15.36%) | 20 Day Moving Average | $8.6(17.91%) | To recent high | -31.3% | To recent low | 78.2% | Market Cap | $753m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |